title: SnapShot: Multiple Myeloma.
abstract: Multiple myeloma (MM) is a plasma cell malignancy characterized by a heterogeneous clinical presentation. Genetic abnormalities are not only key events in the origin and progression of the disease but are also useful tools for prognosis, risk stratification, and therapeutic decision making. Although still incurable, a revolution in the treatment of MM is currently ongoing, leading to a significant improvement of clinical outcome and survival. To view this SnapShot, open or download the PDF.
authors.affiliation: Division of Hematology-Oncology, Mayo Clinic, Scottsdale, AZ 85259, USA.
authors.forename: Esteban
authors.initials: E
authors.lastname: Braggio
authors.affiliation: Division of Hematology-Oncology, Mayo Clinic, Scottsdale, AZ 85259, USA.
authors.forename: K Martin
authors.initials: KM
authors.lastname: Kortüm
authors.affiliation: Division of Hematology-Oncology, Mayo Clinic, Scottsdale, AZ 85259, USA.
authors.forename: A Keith
authors.initials: AK
authors.lastname: Stewart
mesh_terms: D002869:Chromosome Aberrations; D005260:Female; D006801:Humans; D017404:In Situ Hybridization, Fluorescence; D007621:Karyotyping; D008297:Male; D009101:Multiple Myeloma / Q000175:diagnosis / Q000188:drug therapy / Q000235:genetics*; D009154:Mutation; D010950:Plasma Cells / Q000187:drug effects / Q000378:metabolism* / Q000473:pathology; D011379:Prognosis; D015398:Signal Transduction / Q000235:genetics; D016019:Survival Analysis